\
&
Contact us
This was 1 year ago
LocationEnergyVille Genk
The Cluster TWEED and Pôles MecaTech and GreenWin are inviting you to this inter-regional Energy Innovation matchmaking between Wallonia and Flanders on May 15, in EnergyVille, Genk.
This event brings together S3 members, innovators, and enthusiasts from both Wallonia and Flanders for one-day focusing on current EU Innovation funding opportunities. Jump in to share your skills, plans and ideas and meet your future Flemish and/or Walloon partners in the B2B!
The objectives of this initiative are to :
Present regional innovation ecosystems and roadmaps – by the Clusters of innovation
Present open EU call and opportunities – by the EU call responsible
Pitch some practical ideas / ask for competence to build an EU project – by project stimulator
Meet the futurs project partners in B2B – by all innovation actors
More information and registration: here
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.